These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis. Fishel B; Tishler M; Caspi D; Yaron M Ann Rheum Dis; 1989 Jul; 48(7):609-10. PubMed ID: 2774703 [TBL] [Abstract][Full Text] [Related]
5. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis. Trice JM; Pinals RS; Plitman GI Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487 [TBL] [Abstract][Full Text] [Related]
6. Acquired sideroblastic anaemia during treatment of Wilson's disease with triethylene tetramine dihydrochloride. Condamine L; Hermine O; Alvin P; Levine M; Rey C; Courtecuisse V Br J Haematol; 1993 Jan; 83(1):166-8. PubMed ID: 8435326 [TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis. Rosenbaum J; Katz WA; Schumacher HR Ann Rheum Dis; 1980 Apr; 39(2):152-4. PubMed ID: 7387219 [TBL] [Abstract][Full Text] [Related]
8. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis. Bucknall RC Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):114-7. PubMed ID: 122656 [No Abstract] [Full Text] [Related]
9. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis]. Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994 [No Abstract] [Full Text] [Related]
10. Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine. Thomas D; Gallus AS; Brooks PM; Tampi R; Geddes R; Hill W Ann Rheum Dis; 1984 Jun; 43(3):402-6. PubMed ID: 6742902 [TBL] [Abstract][Full Text] [Related]
12. Sideroblastic anaemia associated with lincomycin therapy. Kokkini G; Tsianos E; Kappas A Postgrad Med J; 1983 Dec; 59(698):796-8. PubMed ID: 6657545 [TBL] [Abstract][Full Text] [Related]
13. Lichenoid lesions of the oral mucosa in rheumatoid arthritis patients treated with penicillamine. Blasberg B; Dorey JL; Stein HB; Chalmers A; Conklin RJ J Rheumatol; 1984 Jun; 11(3):348-51. PubMed ID: 6737375 [TBL] [Abstract][Full Text] [Related]
14. [Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis]. Brenner S; Caspi D; Tchetchik R; Krakowski A; Yaron M Harefuah; 1983 Feb; 104(3):94-6. PubMed ID: 6618302 [No Abstract] [Full Text] [Related]
15. [Adverse effects of D-penicillamine in rheumatoid arthritis with reference to prior gold therapy]. Ishihara Y; Fujita A; Ohdoi S; Saitoh K; Katsube S; Azuma T Ryumachi; 1985 Feb; 25(1):15-9. PubMed ID: 4002060 [No Abstract] [Full Text] [Related]
16. Reaction to D-penicillamine in rheumatoid arthritis. Shafar J; Hollanders D Br Med J; 1973 Aug; 3(5874):289. PubMed ID: 4723471 [No Abstract] [Full Text] [Related]
17. Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine. Williams AJ; Fordham JN; Barnes CG; Goodwin FJ Ann Rheum Dis; 1986 Jan; 45(1):82-4. PubMed ID: 3954462 [TBL] [Abstract][Full Text] [Related]
18. [A case of rheumatoid arthritis associated with leukocytopenia during D-penicillamine treatment]. Negishi M; Sato H; Sekine F; Mita S; Ono I; Kobayashi K; Oseto Y; Hamai T; Takahashi T Arerugi; 1982 Jun; 31(6):350-4. PubMed ID: 7181659 [No Abstract] [Full Text] [Related]